Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Addictions Therapeutics Market CAGR Analysis And Future Market Development

The market for addiction treatment therapies has experienced robust expansion lately. Projections indicate a rise from $7.46 billion in 2025 to $7.93 billion in 2026, reflecting a compound annual growth rate of 6.2%. This historical growth trajectory can be linked to factors such as the escalating incidence of substance use disorders, heightened public awareness regarding addiction management, an increase in dedicated treatment facilities, the wider implementation of buprenorphine and naltrexone treatments, and the broader development of healthcare and clinical infrastructures.

The market for addiction treatments is poised for significant expansion in the coming years, projecting a rise to $10.24 billion by 2030, fueled by a compound annual growth rate of 6.6%. This anticipated growth trajectory is underpinned by several key drivers, including the innovation of new therapeutic agents for addiction, augmented financial support from both governmental bodies and private entities for substance use disorder programs, the burgeoning utilization of telehealth and digital platforms for treatment delivery, a more integrated approach to addressing mental health and addiction concurrently, and the broadening scope of collaborations between public and private sectors in addiction care. During this forecast period, several prominent trends are expected to shape the landscape, such as a heightened demand for medication-assisted treatment, the proliferation of both residential and outpatient addiction treatment facilities, increased uptake of remote counseling and telehealth services, a concentrated effort on therapies for nicotine and opioid dependency, and amplified public awareness campaigns concerning substance use disorders.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp

Addictions Therapeutics Market Demand Drivers: What Is Fueling Industry Growth?

The burgeoning consumption of alcoholic beverages stands as a significant catalyst poised to drive expansion within the addiction therapeutics sector. This trend, characterized by the intake of drinks containing ethanol, directly correlates with the demand for treatments designed to combat alcohol dependence. These therapeutic interventions work by mitigating alcohol’s depressant effects and restoring equilibrium between key neurotransmitters, namely glutamate (excitatory) and gamma-aminobutyric acid (inhibitory), thereby diminishing cravings and alleviating withdrawal symptoms like insomnia, anxiety, and restlessness. Illustratively, data from Kirin Holdings Co. Ltd. revealed that global beer consumption in 2023 experienced a marginal rise of roughly 200,000 kiloliters from 2022, reaching approximately 187.9 million kiloliters, which equates to about 296.9 billion standard bottles, signifying a subtle 0.1% year-over-year increase. Consequently, this escalating alcohol intake is a primary driver fueling the growth of the addiction therapeutics market.

Addictions Therapeutics Market Segment Performance And Strategic Opportunities

The addictions therapeutics market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs

2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel

Subsegments:

1) By Buprenorphine: Subutex, Suboxone

2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)

3) By Bupropion: Wellbutrin, Zyban

4) By Disulfiram: Antabuse, Generic Disulfiram

5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges

6) By Varenicline: Chantix (Champix), Generic Varenicline

7) By Other Drugs: Acamprosate, Topiramate, Gabapentin

Addictions Therapeutics Market Innovation Trends: Which Developments Are Transforming The Industry?

Within the addiction therapeutics sector, leading entities are actively engaged in advancing novel solutions, including pharmaceuticals targeting cocaine use disorders (CUD), with the strategic aims of expanding their market reach, boosting sales figures, and augmenting overall profitability. Medications formulated for CUD are intended to provide assistance to those contending with addiction or reliance on cocaine. To illustrate, as of January 2023, Tempero Bio, a biopharmaceutical firm headquartered in the United States, received clearance from the U.S. Food and Drug Administration (FDA) for its product, TMP-301. The unique attribute of TMP-301, which is currently under investigation by the company, is its classification as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Designed with a specific focus on therapeutic applications for cocaine use disorders (CUD), TMP-301 is notable for its considerable efficacy, precise targeting capabilities, and suitability for oral administration, all of which are engineered to effectively manage the excessive glutamate activity linked to CUD.

Addictions Therapeutics Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the addictions therapeutics market are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

Access The Complete Addictions Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Addictions Therapeutics Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the addictions therapeutics market in 2025. The regions covered in the addictions therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model